Scientific Sessions 2025  /  Clearing the Way From Echo to AVR: Addressing Obstacles to Timely Intervention in Severe Aortic Stenosis.  /  Clearing the Way From Echo to AVR: Addressing Obstacles to Timely Intervention in Severe Aortic Stenosis. Provided by Haymarket Medical Education. Supported by an educational grant from Edwards Lifesciences, LLC.
Logo

American Heart Association

  25
  0

Final ID:

Clearing the Way From Echo to AVR: Addressing Obstacles to Timely Intervention in Severe Aortic Stenosis. Provided by Haymarket Medical Education. Supported by an educational grant from Edwards Lifesciences, LLC.

  • Elmariah, Sammy  ( Univ California, San Francisco , San Francisco , California , United States )
  • Lindman, Brian  ( VANDERBILT UNIVERSITY MEDICAL , Nashville , Tennessee , United States )
  • Strom, Jordan  ( Harvard Medical School , Milton , Massachusetts , United States )
  • Pellikka, Patricia  ( MAYO CLINIC COLLEGE MEDICINE , Rochester , Minnesota , United States )
    • Author Disclosures:
    Sammy Elmariah: DO have relevant financial relationships ; Consultant:Edwards Lifesciences:Active (exists now) ; Individual Stocks/Stock Options:Prospect Health:Active (exists now) ; Research Funding (PI or named investigator):Medtronic:Past (completed) ; Research Funding (PI or named investigator):Abbott:Active (exists now) ; Research Funding (PI or named investigator):Edwards Lifesciences:Active (exists now) | Brian Lindman: DO have relevant financial relationships ; Research Funding (PI or named investigator):Edwards Lifesciences:Active (exists now) ; Consultant:Astra Zeneca:Active (exists now) ; Consultant:Kardigan:Active (exists now) ; Consultant:Anteris:Active (exists now) ; Consultant:Medtronic:Active (exists now) | Jordan Strom: DO have relevant financial relationships ; Consultant:Edwards Lifesciences:Active (exists now) ; Consultant:Alnyam:Past (completed) ; Consultant:Bristol Myers Squibb:Past (completed) ; Consultant:EVERSANA Lifeciences:Active (exists now) ; Research Funding (PI or named investigator):EVERSANA Lifesciences:Active (exists now) ; Advisor:Ultrasight:Active (exists now) ; Advisor:EchoIQ:Active (exists now) ; Research Funding (PI or named investigator):EchoIQ:Active (exists now) ; Research Funding (PI or named investigator):Philips Healthcare:Active (exists now) ; Consultant:Philips Healthcare:Active (exists now) ; Research Funding (PI or named investigator):Anumana:Past (completed) ; Research Funding (PI or named investigator):Bracco Diagnostics:Active (exists now) ; Consultant:Bracco Diagnostics:Active (exists now) ; Advisor:Ultromics Ltd.:Active (exists now) ; Research Funding (PI or named investigator):Ultromics Ltd.:Past (completed) | Patricia Pellikka: DO have relevant financial relationships ; Research Funding (PI or named investigator):Edwards Lifesciences:Past (completed) ; Royalties/Patent Beneficiary:UpToDate:Active (exists now) ; Advisor:Alnylam:Active (exists now) ; Advisor:Astellas:Past (completed) ; Research Funding (PI or named investigator):Ultromics:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Clearing the Way From Echo to AVR: Addressing Obstacles to Timely Intervention in Severe Aortic Stenosis.

Saturday, 11/08/2025 , 06:00PM - 07:30PM

Industry Satellite Symposia

More abstracts from these authors:
Contemporary Diagnosis, Management, and Outcomes of Patients With Low-Gradient Severe Aortic Stenosis: A Multi-Center Analysis

Vemulapalli Sreekanth, Genereux Philippe, Lindman Brian, Elmariah Sammy, Pibarot Philippe, Peterson Benjamin, Rodriguez Evelio, Leon Martin, Mack Michael, Eberst Kyle

Presentation

Lindman Brian, Elmariah Sammy, Genereux Philippe

You have to be authorized to contact abstract author. Please, Login
Not Available